Leuprolide and Azithromycin: Interaction Details
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Leuprolide and Azithromycin interaction:
Azithromycin
- Zithromax
- Zithromax Single Dose Packets
- Zithromax Tri-Paks
- Zithromax Z-Paks
- Zmax
- Azasite
Leuprolide
- Lupron
- Fensolvi
- Camcevi
- Lutrate
- Vabrinty
- Eligard
- Lupron Depot
- Lupron Depot-PED
- Camcevi Etm
- Leuprolide Acetate Depot
- Lutrate Depot
What Happens When You Take Leuprolide With Azithromycin
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Androgen deprivation induced by leuprolide can lengthen the QT/. In patients who are also receiving medications known to prolong the , weigh whether the benefits of androgen deprivation therapy exceed the possible risks.14
Whenever possible, do not combine leuprolide with agents that prolong the QT interval. When the combination cannot be avoided, steer clear of drugs that produce electrolyte disturbances (ie, or ),2 and consider checking and electrolytes at regular intervals.14
The Leuprolide and Azithromycin Interaction, Explained
Both azithromycin (an antibiotic) and leuprolide (a hormone-lowering treatment, often used for prostate cancer) can affect the heart's electrical rhythm. Each may slightly lengthen the , a measure seen on an . Taking them together could add to that effect, which in rare cases may lead to an irregular heartbeat. This concern is based mainly on theory rather than on proven cases.
Do not stop either medicine on your own. Your pharmacist or doctor can weigh the benefits, check your heart rhythm and blood salts if needed, and help keep you safe. Tell them about any fainting, dizziness, or fast or fluttering heartbeat.
QT/ (). Azithromycin has known QT-prolonging potential; androgen deprivation therapy with leuprolide may also prolong . Evidence is theoretical; onset unspecified; severity rated major.
- Reassess benefit vs risk of ADT in patients on QT-prolonging agents; avoid when possible.
- If coadministration is required, avoid agents causing or .
- Consider periodic and electrolyte (K, Mg) monitoring.
- Consider baseline risk factors (cardiac disease, other QT-prolonging drugs, ).
See the 4 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Leuprolide and Azithromycin Interact
The likely mechanism
How to Manage the Leuprolide and Azithromycin Interaction
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team may weigh whether the combination is needed, and may choose another option when possible.
- If you need both, your team may monitor you more closely, such as periodic heart tracings () and blood tests for potassium and magnesium.
- They will try to avoid other medicines that lower these electrolytes.
- Tell your pharmacist or prescriber about all your medicines and any heart conditions.
- Report fainting, dizziness, or palpitations promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Leuprolide or Azithromycin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes
A study of male patients on androgen deprivation therapy (ADT) analyzed individual case safety reports from VigiBase, the international pharmacovigilance database, and identified 184 cases of acquired long-QT syndrome (aLQTS) and/or (TdP; 11% fatal) and 99 cases of sudden death associated with ADT. Most ADT-associated cases of aLQTS/TdP (62%) and sudden death (88%) arose without exposure to other drugs known to raise TdP risk.
Some events did involve exposure to 1 drug or to 2 or more drugs with conditional, possible, or known TdP risk: 23% and 43% of aLQTS/TdP events, and 18% and 22% of sudden death events, respectively. The drugs classed as ADTs were abiraterone, gonadotropin-releasing hormone and , nonsteroidal androgen receptor indicated for prostate cancer, and 5-alpha-reductase inhibitors indicated for androgenic alopecia and prostatism.
Of the 10 ADTs evaluated, 7 showed a disproportional association (reporting odds ratio, 1.4 to 4.7) with aLQTS, TdP, or sudden death: leuprorelin, goserelin, triptorelin, degarelix, bicalutamide, finasteride, and dutasteride. The median patient age was about 76 years.
The median time to onset was 170 days (range, 7 to 4884 days) for aLQTS/TdP events and 92 days (range, 0.25 to 4984 days) for sudden death events. Patients were receiving ADT mainly for prostate cancer, and some were treated for prostatism and androgenic alopecia. Most patients were on ADT monotherapy (83%), while 17% received ADT combination therapy.3
Leuprolide and Azithromycin: Common Questions
How serious is the Leuprolide and Azithromycin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Leuprolide and Azithromycin interaction managed?
Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team may weigh whether the combination is needed, and may choose another option when possible. If you need both, your team may monitor you more closely, such as periodic heart tracings () and blood tests for potassium and magnesium. They will try to avoid other medicines that lower these electrolytes.… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Leuprolide and Azithromycin Interaction
Ask in your own words about taking Leuprolide and Azithromycin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (4)
- Product Information: CAMCEVI ETM subcutaneous emulsion, leuprolide subcutaneous emulsion. Foresee Pharmaceuticals (per FDA), Newark, DE, 2025. DailyMed
- Lyon AR, Lopez-Fernandez T, Couch LS, et al: 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022; 43(41):4229-4361. DailyMed
- Salem JE, Yang T, Moslehi JJ, et al: Androgenic effects on ventricular repolarization: a translational study from the international pharmacovigilance database to iPSC-cardiomyocytes. Circulation 2019; 140(13):1070-1080. DailyMed
- Product Information: ELIGARD(R) subcutaneous injection suspension, leuprolide acetate subcutaneous injection suspension. Tolmar Pharmaceuticals, Inc. (per FDA), Fort Collins, CO, 2016.
Other Serious Interactions of Leuprolide and Azithromycin
Also serious with Azithromycin
- ColchicineContraindicated
- DronedaroneContraindicated
- LevoketoconazoleContraindicated
- PimozideContraindicated
Also serious with Leuprolide
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Azithromycin
- GrapefruitMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- OleanderMajor
- Sida CordifoliaMajor
- + 84 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.